Tocilizumab ameliorates clinical symptoms in polymyalgia rheumatica.
Hagihara
Keisuke
K
Kawase
Ichiro
I
Tanaka
Toshio
T
Kishimoto
Tadamitsu
T
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D011111:Polymyalgia Rheumatica / Q000628:therapy*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; C502936:tocilizumab